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Abstract 
 
A new pyrazole containing ligand, 5-methyl-3-formylpyrazole-N(4)-dihexylthiosemicarbazone 
(HMPzNHex2), and a host of its cobalt(III) and nickel(II) complexes,  [Co(MPzNHex2)2]X·mH2O 
and [Ni(HMPzNHex2)2]X2·nH2O  (X= Cl, Br, ClO4, BF4
 and NO3; m = 0 for Cl, Br, BF4 & NO3
 and 
1.5 for ClO4; n = 0 for Br, ClO4, BF4 & NO3 and 2 for Cl), respectively, have been synthesized and 
characterized by elemental analyses, magnetic measurements (polycrystalline state), 1H NMR (for 
the ligand and its Co(III) complexes), electronic and IR spectral parameters. All the reported Co(III)  
and Ni(II) complexes are cationic in nature and behaving as 1:1 and 1:2 electrolytes, respectively, in 
MeOH. Electronic spectral data of the complexes categorize them as having distorted octahedral 
coordination geometry. IR spectral features (4000-/450 cm-1) specify a monodeprotonated / neutral 
tridentate (NNS) function of the ligand, HMPzNHex2 coordinating to the Co(III) / Ni(II) via the 
pyrazolyl (tertiary) ring nitrogen, azomethine nitrogen and thiolato / thioketo sulfur atom. 1H NMR 
spectral data (in CDCl3 at 400 MHz) for the primary ligand and those of its Co(III) complexes are in 
agreement with the proposition of bonding sites evidenced from IR data. The single crystal x-ray 
data of I (C2/c (#15); monoclinic) and II (P-1 (#2); triclinic) have confirmed a CoN4S2 and a 
NiN4S2 octahedral coordination, respectively. The pair of monoprotic / neutral coordinating ligands 
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is more or less orthogonal to each other in the complex species. The data obtained from DFT 
calculations are reasonably in agreement with the UV-Vis spectral assignment and the structures of 
the complex species. Although the ligand and the tested metal ion complexes are capable of 
inhibiting microbial growth, the cobalt complexes can be promoted as better antimicrobial agents.  
 
Keywords: Cobalt(III) complexes; Nickel(II) complexes; Thiosemicarbazone; X-ray 
crystallography; Antimicrobial activities. 
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1. Introduction: 
A plethora of literature on thiosemicarbazones has been published wherein different aspects of 
their coordination behavior leading to excellent biological activities viz., antitumor, antibacterial, 
fungicidal, anti-inflammatory, antiviral, anticancer, antifungal and anti-HIV activity etc. are 
discussed [1-16]. Thiosemicarbazones are an outstanding class of multidentate ligands, 
comprising of potential binding sites accessible to different types of metal ions and with a wide 
range of analytical applications [17]. The well established biological activities of 
thiosemicarbazone class of compounds  are often related to their chelating ability with transition 
metal ions, bonding through N, N, and S atoms [18] or O, N and S atoms [3,19,20]. It has been 
observed that the substituent(s) present at the N(4)-position affect the activity of the 
thiosemicarbazones and their metal ion complexes [21]. A bulky substituent present at the N(4) 
position of the thiosemicarbazone chain might bring about an enhancement of antimicrobial 
activity compared to an un-substituted one, possibly due to an increase in lipophilicity, which 
influences the tendency of a molecule to be transported through biological membranes [22a]. On 
the other hand, different counter anions present in the complexes of a particular metal ion play 
definitive roles in enhancement of biological activities [22b,c]. In recent years, Co(III) 
thiosemicarbazone complexes have drawn  much attention as anticancer drugs and potential 
hypoxia-activated pro-drugs [23-31]. Ni(II) thiosemicarbazone complexes containing multiple 
donor sites have now been more comprehensively studied for their fascinating structural 
diversities and wide applications as antibacterial, antifungal and anticancer agents [32-43].  A 
variety of factors can be cited to be accountable for their flexibility in coordination, such as 
intramolecular hydrogen bonding, bulkier coligand, steric crowding on the azomethine carbon 
atom and π–π stacking interactions [44-49]. A potential donor atom or a functional group which 
is capable of furnishing a variety of coordination modes, present in the primary ligand systems, 
plays crucial role in providing flexibility to the ligands which can coordinate to the transition 
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metal ion in a neutral or deprotonated form, producing mono or poly nuclear complexes with 
novel topologies and particular properties [50–58]. As a part of syntheses and characterizations 
of new thiosemicarbazones and their complexes and in continuation of our earlier publications 
[55, 56], this communication is intended to report the synthesis, physico-chemical & 
spectroscopic characterization and antimicrobial studies of a series of Co(III) and Ni(II) 
complexes having different counter ions with the title ligand, HMPzNHex2, along with the X-ray 
crystallography and DFT study of [Co(MPzNHex2)2]ClO4·1.5H2O (I) and 
[Ni(HMPzNHex2)2]Cl2·2H2O (II). 
 
2. Experimental 
All the solvents and reagents used were of reagent grade / molecular biology grade, and used as 
commercially purchased without further purification. Spectroscopy grade solvents were used for 
spectral and conductance measurements. 
 
2.1. Physical measurements 
Elemental analyses (C, H and N) were done with a Perkin–Elmer 2400 CHNS/O analyzer. The 
cobalt contents of the complexes were determined by complexometric titration using EDTA, 
while the nickel contents of the complexes were determined gravimetrically as anhydrous 
dimethylglyoximatonickel(II). The molar conductance of the complexes in methanol solutions 
was measured with a Systronics 306 digital conductivity meter. Magnetic susceptibilities of the 
complexes in polycrystalline state were measured on a PAR 155 sample vibrating magnetometer. 
1H NMR spectra for the ligand and cobalt(III) complexes were recorded with a Bruker AC 400 
superconducting FT NMR spectrometer. High resolution mass spectroscopy (HRMS) was 
performed with a Waters XEVO G2-S QTof mass spectrometer. The electronic spectra (in 
MeOH) were recorded on a Shimadzu UV-2401PC spectrophotometer. IR spectra               
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(4000–400 cm-1) were recorded on a Perkin Elmer L120-000A FT-IR spectrophotometer with 
KBr pellets. 
2.2. Synthesis of 5-methyl-3-formylpyrazole-N(4)-dihexylthiosemicarbazone (HMPzNHex2):  
The title ligand, 5-methyl-3-formylpyrazole-N(4)-dihexylthiosemicarbazone (HMPzNHex2) 
(Fig.1a), was synthesized following a similar but suitably modified method [59a]. Which 
involved conversion of 5-methylpyrazole-3-carbohydrazide [59b] into its benzene sulphonyl 
derivative, followed by treatment with the S-methyldithiocarbazate [59c] in alkaline ethylene 
glycol medium (160°C) leading to the pale yellow solid S-methyldithiocarbazate of 5-methyl-3-
formylpyrazole (HMPzSMe). Finally the transamination [60] of resulting HMPzSMe with 
dihexylamine, gave the desired product. White crystallised product (from ethanol) obtained with 
a yield of ~75%, melted at 159-1600C. Anal. Found: C, 61.6; H, 9.4; N, 19.8; Calc. for 
C18H33N5S: C, 61.5; H, 9.5; N, 19.9%. HRMS m/z: Calc. for C18H33N5S [M+H]
+ 352.5611, 
found 352.2650. IR (KBr):  (cm-1) = 3165(NH), 1604 (CH=N, azomethine), 1499 (C=N, 
pyrazole), 1087 (N-NPZ) and 869 ((C=S)). 1H NMR (CDCl3) (ppm):  12.83 (s, 1H, NH pyrazole); 
11.51 (s, 1H, NH imino), 7.27 (s, 1H, CH=N), 2.34 (s, 3H, C5-CH3), 6.12 (s, 1H, C4-H), 3.64 (t, 
4H), 1.65 (m, 4H), 1.23 (m, 12H), 0.79 (t, 6H).  
  
2.2.1. Preparation of the Co(III) and Ni(II) complexes 
The reported Co(III) and Ni(II) complexes (Figs. 1b and 1c) of the title ligand, HMPzNHex2 were 
prepared by refluxing ethanol solutions of the ligand, (1.05 mmol) and the corresponding 
hydrated Co(II) or Ni(II) salts (0.525 mmol) in water bath for ~1 h. The desired Co(III) or Ni(II) 
complexes, in each case, crystallized out on slow evaporation of the dark brown or green 
solutions, respectively. The solids obtained were filtered off, washed with cold ethanol and were 
dried over anhydrous CaCl2. The yields of the products were found to be ~75-80%. Orange 
crystals of [Co(MPzNHex2)2]ClO4·1.5H2O (I) and  green crystals of 
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[Ni(HMPzNHex2)2]Cl2·2H2O (II) were found suitable for X-ray diffraction study. Anal. Calc. 
(%) for C
36
H
67
ClCoN
10
O
5.5
S
2
 (I): C, 48.8; H, 7.3; N, 15.8; Co, 6.6. Found (%): C, 48.7; H, 7.2; 
N, 15.7; Co, 6.7. HRMS m/z: Calc. for C36H64N10S2Co [M-(ClO4+1.5H2O)]
+  759.4088, found 
759.3989. IR (KBr): v (cm-1) =1575 (vCH=N, azomethine), 1505 (vC=N, pyrazole), 1146 (vN–NPZ) 
and 809 ((C=S)). UV-Vis (MeOH, λmax, nm): 227 (π → π*), 325 (n → π*), 391 (LMCT). 1H 
NMR (CDCl3) (ppm):  12.99 (s, 1H, NH pyrazole), 8.39 (s, 1H, CH=N), 2.59 (s, 3H, C5-CH3), 
6.17 (s, 1H, C4-H), 3.74 (t, 4H), 1.67 (m, 4H), 1.27 (m, 12H), 0.89 (t, 6H).    
Anal. Calc. (%) for C
36
H
70
Cl
2
N
10
NiO
2
S
2
 (II): C, 49.8; H, 7.6; N, 16.1; Ni, 6.8. Found (%): C, 
49.3; H, 7.4; N, 16.4; Ni, 6.9. HRMS m/z: Calc. for C36H66N10S2Ni [M-(2Cl+2H2O)]
+  761.7996, 
found 761.4103. IR (KBr): v (cm−1) = 1562 (vCH=N, azomethine), 1514 (vC=N, pyrazole), 1129 (vN–
NPZ) and 846 (C=S). UV-Vis (MeOH, λmax, nm): 223 (π → π*), 307 (n → π*), 359 (LMCT).  
Caution! Metal ion complexes with organic ligands containing perchlorate as anion are 
potentially explosive and should be handled with care. 
 
2.3. Structure determination 
X-ray diffraction data for compounds I and II were collected at 125 K using the St Andrews 
Automated Robotic Diffractometer (STANDARD) [61], consisting of a Rigaku sealed-tube 
generator, equipped with a SHINE monochromator [MoKα radiation (λ = 0.71075Å)] and a 
Saturn 724 CCD area detector, coupled with a Microglide goniometer head and an ACTOR SM 
robotic sample changer. Intensity data were collected using ω steps accumulating area detector 
images spanning at least a hemisphere of reciprocal space. All the data were corrected for 
Lorentz polarization effects. A multiscan absorption correction was applied by using 
CrystalClear [62]. Structures were solved by direct (SIR2004 [63]) or charge-flipping (Superflip 
[64]) methods and refined by full-matrix least-squares against F2 (SHELXL-2013 [65]). Non-
  
 7  
hydrogen atoms were refined anisotropically, and hydrogen atoms were refined using a riding 
model, except for N-H hydrogens in I which were located from the difference Fourier map and 
refined isotropically subject to a distance restraint. Due to the data-quality in II the equivalent 
hydrogens could not be located. Disorder was found in the orientation of the ClO4
– anion in I, in 
one C6 chain in I, and in parts of two of the C6 chains in II. All cases of disorder were modelled 
with split atom positions, and the minor components of the disorder, except the disordered Cl in 
I, were refined isotropically. Both cases of disorder in I were modelled with distance and angle 
restraints as well as similarity restraints to thermal motion parameters, while the disorder in II 
required with similarity restraints on thermal motion only. Despite modelling disorder with split 
atom positions in I, thermal ellipsoids for the major components of the disordered atoms 
remained large, suggesting that further disorder was present; however this could not be 
successfully refined. Compound II was affected by non-merohedral twinning, with a twin law of 
[-1 0 0 0.01 1 -0.352 0 0 -1] and a refined twin fraction of 0.41. There were suggestions that 
further twinning might also be occurring, but this could not be successfully incorporated into the 
model. All calculations were performed using the CrystalStructure [66] interface. 
 
2.4. Computational details 
All the quantum chemical calculations were performed using density functional theory (DFT) 
implemented in GAUSSIAN 09 [67]. The geometry of the complex-I and complex-II were fully 
optimized using M062X hybrid functional and 6-31g (d, p) basis set. The absorption spectra were 
simulated using Time Dependent Density Functional Theory (TD-DFT). All the computational 
study was carried out in Methanol solvent using Polarizable Continuum Model (PCM) 
implemented in Gaussian 09. The orbital contribution was calculated by GaussSum [68]. 
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2.5. Antimicrobial activity 
     All the 11 synthetic compounds were dissolved in dimethyl sulfoxide, (DMSO), while 
maintaining final solvent concentration up to 1%. Amoxicillin, a clinically recommended 
antibacterial agent was employed as the reference material [56]. In vitro antimicrobial  potential of 
all the synthetic compounds under investigation were evaluated against three Gram negative 
bacterial strains, namely Salmonella enterica ser. typhi SRC, Proteus vulgaris OX19, 
Enterobacter aerogenes 10102 and one Gram positive bacterial strain (Bacillus subtilis 6633), 
which were obtained from Microbial Type Culture Collection and Gene Bank (MTCC), Institute of 
Microbial Technology, Chandigarh, India. Minimum inhibitory concentrations (MIC) of the 
compounds were determined by tube dilution method with different concentrations of them as per 
standard protocol [69]. Different concentrations of all the compounds were made in sterilized LB 
broth and then overnight culture of individual bacterial strain was inoculated into respective tubes 
and incubated at 37°C for 24 hours. The activity was measured by turbidity in the broth with UV-
Vis spectrophotometer at 600nm. Bacterial susceptibility of the compounds was assessed 
following agar well diffusion method and the degree of inhibition was determined by measuring 
the diameter of inhibition zones (mm) [70]. Two strains, one Gram positive and one Gram 
negative (Bacillus subtilis 6633 and Enterobacter aerogenes 10102) were monitored for the study 
of growth kinetics in presence of the compounds.  
 
3.     Results and discussion: 
3.1. Spectroscopic characterization of the ligand, HMPzNHex2 
The title ligand, HMPzNHex2 was characterized by elemental analyses (C, H and N), IR, 
1H 
NMR and high resolution mass spectral (HRMS) studies. The characteristic IR bands (cm-1) at 
3165 (NH), 1604 ((CH=N)), 1499 ((C=N)), 1087 (N-NPZ) and 869 ((C=S)) were in good agreement 
with the structure in Fig.1. The 1H NMR spectrum of the free ligand in CDCl3 furnished singlets 
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at δ = 2.34 (3H), 6.12 (1H), 12.83 (1H), 7.27 (1H) and 11.51(1H) assigned to C5-CH3, C4-H,    
N1-H of the pyrazole ring, -CH=N and NH imino, respectively. The spectrum also showed 
triplets at δ = 3.64 (4H) and 0.79 (6H); multiplets at δ = 1.65 (4H) and 1.23 (12H) ascribed for 
the dihexyl side chain. 
 
3.2. Characterization of the Co(III) and Ni(II) complexes 
All the metal ion complexes, reported here, gave satisfactory C, H, N and metal analyses, and 
corroborated to the general composition: [Co(MPzNHex2)2]X·mH2O and 
[Ni(HMPzNHex2)2]X2·nH2O (X= Cl, Br, ClO4, BF4 and NO3; m =1.5 for ClO4 and n = 2 for Cl). 
The Co(III) and Ni(II) complexes behaved as 1:1 and 1:2 electrolytes, respectively, in methanol 
(300C) [71]. As expected, all the spin-paired Co(III) complexes reported here are diamagnetic (at 
~/300 K) in nature, while the normal spin free Ni(II) complexes are paramagnetic with magnetic 
moments µeff =/2.89-3.20 BM (Table 1). 
 
3.2.1 Spectral studies 
3.2.1.1 IR spectroscopy 
A comparison of the characteristic IR bands of the free ligand with those of its metal ion 
complexes, reported here, offered positive indications regarding the bonding sites of the primary 
ligand. A negative shift was found to occur in (υCH=N) band (1604 cm-1) in the free ligand 
spectrum to the lower value (1557-1575 cm-1) (Table S1) in its complexes, pointed out 
coordination of the azomethine nitrogen to the central metal ion; the appearance of IR bands at 
469-/497 cm-1 in the spectra of the complexes can then be assigned to υ(M-N) [54a]. The IR band 
obtained at 1499  cm-1 in the free ligand spectrum, assignable to υ(C=N) (pyrazole ring), has been 
found to suffer positive shift to  higher frequency region 1504 – 1516 cm-1 in complex species, 
indicating the participation of the tertiary ring nitrogen atom (2N) as a possible bonding site. IR 
  
 10  
band observed at 1087 cm-1 (N-NPZ) in the primary ligand, was also found to shift to a higher 
frequency region 1129 – 1146 cm-1 in complexes, which provided further information of the 
participation of the tertiary ring nitrogen atom (2N) in bonding  [55,56,72,73]. A strong band 
appeared at 869 cm-1 in the free ligand spectrum, assigned to υ(C=S), had been found to shift to 
lower frequency region (797-847 cm-1) in the complexes, pointing towards coordination of the 
sulfur in its thioenol or thioketo form to metal ion [54]. 
 
3.2.1.2 Electronic spectroscopy and TD-DFT study 
The electronic spectra of the Co(III) complexes in MeOH solution exhibited two bands in the 
regions 225-229 and 324-325 nm,  which might be ascribed to intraligand π→π* and n→π*, 
transitions, respectively [74a, 75-76]. The spectra also displayed a shoulder at 389-393 nm, 
possibly due to S→Co(III) charge transfer bands (LMCT) [54a]. The UV–Vis absorption spectra 
of  Ni(II) complexes in methanol displayed two bands in the region 203-223 and 297-307 nm, 
might be assigned for intraligand  π→π* and n→π* transitions, respectively [74b, 76]. The 
shoulder found at 359-360 nm might be due to S→Ni(II) charge transfer bands (LMCT) [54a] .  
TD-DFT calculation was performed on complexes I and II (as reference) to explain the 
experimental absorption spectra. The experimental UV–Vis data are reasonably in agreement 
with the quantum chemical calculations from the TD-DFT study. The vertical excitations with 
their band position, oscillator strength and character assignment of the transition from TDFT are 
given in (Table 2). In complex I, the simulated transitions at 234.97 nm (λexp = 227.82 nm) and 
292.93 nm (λexp = 325.51 nm) are correspond to intraligand transition bands (π→π* and n→π* 
respectively). The peak resolved theoretically at 359.67 nm resembles the shoulder obtained 
experimentally (λexp = 391.49 nm) and can be assigned a S→Co(III) charge transfer bands 
(LMCT) (Fig. 2). Similarly, for complex II, all the experimentally resolved peaks are reasonably 
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in agreement with the simulated peaks (Fig. 3). The compositions and energies of the frontier 
molecular orbitals of the complex are given in Tables S2 & S3. 
 
3.2.1.3  1H NMR spectral study 
 1H NMR spectral data of the free ligand and those of its Co(III) complexes are summarized in  
Table 3. A close scrutiny of the data revealed that:  (i) After complexation, the disappearance of 
the imino 2NH (at the thiosemicarbazone part in the free ligand molecule) peak at δ =/11.51, 
signifying that the ligand experienced deprotonation and coordinated to the Co(III) ion through 
the thiol sulfur. (ii) The peaks for terminal -N(n-Hex2)2 groups in the uncomplexed ligand 
suffered little down-field shifts in the complex species, which is indicative of coordination of the 
thiol sulfur to Co(III) ion, due to which reduction  of electron density at the terminal N-atom of 
N(n-Hex2)2 occurred. (iii) Peak at δ = 7.27 due to azomethine CH proton in the free ligand, 
experienced maximum downfield shift in the complex species (δ = 8.39-8.44), pointing to the 
coordination of the azomethine nitrogen to the Co(III) ion. (iv) 4CH (pyrazole ring) suffered 
down field shift from δ = 6.12 (free ligand) to δ = 6.15-6.19 in the complexes justified the 
coordination of the pyrazole ring 2N (tertiary) to the Co(III) ion. 1H NMR spectral studies, thus, 
authenticated the binding modes of the primary ligand, HMPzNHex2 in forming complexes with 
Co(III), through the pyrazolyl ring nitrogen 2N (tertiary), azomethine nitrogen and thiolato sulfur 
atom [55,56], as ascertained from the IR spectroscopic data. 
 
3.3. Crystal structures of [Co(MPzNHex2)2]ClO4·1.5H2O (I) and [Ni(HMPzNHex2)2]Cl2·2H2O 
(II) 
 
Views of the X-ray structures of the complexes (I and II) together with the atom numbering 
schemes were shown in Figs. 4 and 5. The crystallographic data and refinement parameters were 
summarized in Table 4. A [Co(MPzNHex2)2]
+ cation, a ClO4 anion and 1.5 molecules of water 
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of crystallization formed the crystallographic asymmetric unit in I; whereas the same in II had 
been constituted by a [Ni(MPzNHex2)2]
++ cation, two Cl anions and two molecules of water of 
crystallization. In both I and II the central metal ions had distorted octahedral coordination, the 
distortion being more prominent in the Ni(II) complex (Table 5). A pair of mono-deprotonated 
ligands, (MPzNHex2), was found to coordinate to the Co(III) ion through the pyrazolyl (tertiary) 
ring nitrogen atoms [N1, N31], the hydrazinic chain nitrogen atoms [N8, N38], and the thiolato 
sulfur atoms [S10, S40] in complex I. On the other hand, the mode of coordination in complex II 
remained the same; with the exception that the pair of coordinating ligands did not undergo 
deprotonation and behaved as neutral species. In both complexes I and II, two molecules of the 
NNS tridentate ligand, in either mononegative or neutral forms, respectively, coordinated to the 
metal ion to form four five-membered chelate rings (M-S10-C10-N9-N8, M-S40-C40-N39-N38, 
M-/N1-C5-C7-N8 and M-N31-C35-C37-N38; M = Co, Ni). The two azomethine nitrogen atoms, 
N8 & N38, were oriented trans to each other, while both the pyrazolyl ring nitrogen atoms, N1 & 
N31, and the sulfur atoms, S10 & S40, were in a cis orientation.  
The lessening of the endocyclic angles at the hydrazinic nitrogens, N9 and N39, in complex I, 
might be due to deprotonation, occurred at these points; no such reduction was found to happen 
with the corresponding angles in complex II, where no deprotonation occurred at the hydrazinic 
nitrogen atoms (Table 5). As a result of which, the double bond character of the N9-C10 & N39-
C40 bonds in complex I was enhanced with subsequent decrease in the double bond character of 
the C10-S10 & C40-S40 bonds; this had not been observed in complex II, where deprotonation 
did not occur. In both I and II, the reduction in the bond distances formed between the metal ions 
and the azomethine nitrogen atoms, N8 & N38, in comparison to the bond distances with the 
pyrazolyl (tertiary) ring nitrogen atoms, N1 & N31 (Table 5), might be ascribed by the fact that 
among the azomethine nitrogen and the pyrazolyl nitrogen, the former was as a stronger base. 
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Table 6 provided the details of the hydrogen bonding interactions prevailed in the structures. All 
the potential hydrogen donors, namely, the pyrazolyl secondary nitrogen atoms (N2 and N32) in 
both complex I & II, and the hydrazinic nitrogen atoms (N9 and N39) in complex II, were 
engaged  in classical hydrogen bond formation with the water, perchlorate oxygen and chlorine 
atoms. While the hydrogen atoms on water molecules could not be located, details of hydrogen 
bonding can be deduced from the positioning of the waters in the cases in I and II, and the nature 
of the resulting hydrogen-bonded supramolecules determined. In I, a two dimensional hydrogen-
bonded network was formed in the (1 0 0) plane, comprising one dimension chains of hydrogen-
bonded water molecules and perchlorate anions, linked together by complex cations. In II a 
simple one-dimensional hydrogen-bonded chain had been formed, running along the 
crystallographic ac diagonal axis. The hydrogen bonding and crystallographic packing of the 
complexes was shown in Figs. 6 and 7. 
Computational study was performed using density functional theory (DFT) with M062X hybrid 
functional and 6-31g (d, p) basis set to optimize the geometry of complexes I and II. Both the 
octahedral complexes were fully optimized (Fig. 8).  A comparison of the bond length and bond 
angles between the experimental and the optimized structures of both the complexes is given in 
Table 5. The harmony between the crystal structures and the optimized structures indicates that 
the level of calculation is fairly good for this type of molecules. 
 
3.4. Antimicrobial activity 
The study revealed that all the synthesized compounds and the ligand inhibited microbial growth. 
The respective MIC values and growth inhibition zone diameters for these compounds were 
presented in Tables 7 and 8. Although the ligand (MS1) exhibited potential antibacterial activity 
against all four bacterial strains with MIC values within the range of 200 to 500 μg mL−1, it was 
found most effective against B. subtilis 6633 and P. vulgaris OX19, with the MIC values of 200 
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and 300 μg mL−1, respectively. The reported cobalt compounds (MS2, MS3, MS4, MS5 and 
MS6) showed antibacterial activities against all Gram-positive and Gram-negative bacteria, with 
MIC range of 225 to 1675 μg mL−1. On the other hand five nickel compounds (MS7, MS8, MS9, 
MS10 and MS11) also exhibited a wide range of antibacterial activity with comparatively higher 
MIC values (775 - 1650 μg mL−1). It suggests that the cobalt complexes possess greater 
antimicrobial potential compared to the nickel complexes.  Further the anionic groups contributed 
to the antimicrobial potential of the complexes more evident in case of the Co(III) complexes in 
the following order of variation: fluoroborate > perchlorate > nitrate > bromide > chloride. In case 
of Ni(II) complexes, the maximum antibacterial activity was conferred by fluoroborate followed 
by perchlorate. In contrast the minimum antibacterial activity was observed in case of chloride, 
bromide or nitrate against different bacteria. So, it can be concluded that all the synthesized 
compounds and the ligand tested have varied antibacterial potential against selected 
representatives from both Gram positive and Gram negative categories. It might have some 
connotations for their wide window of antibacterial activities. 
Agar well diffusion study showed that MS3, 4, 7, 8, 10, 11 showed higher antimicrobial 
efficiency against S. typhi,  MS1, 2, 5, 9 against E. aerogenes and MS2, 6 against B. subtilis as 
evident from the respective inhibition zone diameters.  This also finds support from degree of 
growth restriction evident in the bacterial growth kinetics. The cobalt compound MS2 was found 
effective against both Gram positive (B. subtilis) and Gram negative (E. aerogenes). P. vulgaris 
showed the least vulnerability to majority of the complexes (MS1, 2, 3, 4, 10, 11).   S. typhi 
offered higher tolerance against two cobalt compounds (MS5 and 6) while B. subtilis against two 
nickel compounds (MS7, 8). It is noteworthy that one nickel compound (MS 11) offered the 
highest growth inhibition zone against S. typhi. No concrete inference on the comparative 
efficiencies of tested complexes can be drawn based on the growth inhibition zone diameters 
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derived  from the agar well diffusion study because of the fact that the concentrations of the 
selected Co- and Ni- complexes were different and set at respective MICs. 
Growth kinetics study performed with two different bacterial species (Enterobacter aerogenes 
10102 and Bacillus subtilis 6633) subjected to the synthetic compounds presented significant 
growth inhibition induced by these chemical candidates as illustrated by the in vitro growth 
curves (Figs. 9 and 10). In the control set in absence of any complex or standard antibiotic 
Bacillus subtilis 6633 (a Gram positive bacterial strain) showed an exponential growth pattern up 
to 12 hour followed by a stationary phase. When subjected to cobalt and nickel compounds  
growth was dampened immediately under exposure to MS 4, 6, 8 that continued up to 2nd hour. In 
case of  MS1, 2, 3, 9, 10 marked decline in growth rate was observed between 2nd and 4th hour of 
incubation. Against MS 11 the bacteria showed dampened growth all through after 6th hour 
onwards. High recovery in growth of the bacteria was witnessed in presence of all cobalt 
compounds (MS2, 3, 4, 5, 6) and one nickel compound (MS7). In contrast low rates of growth 
recovery were observed for the bacteria in presence of all the nickel compounds (MS8, 9, 10 and 
11, except MS7) and MS1. There observed significant variations (P<0.05) among the nickel 
compounds in restricting growth in the following order:  MS11 > MS10 > MS9 > MS8 showing 
their relative bacteriostatic efficiency. For Enterobacter aerogenes 10102 (a Gram negative 
bacterial strain)  in the control set in absence of any complex or standard antibiotic showed an 
exponential increase in growth up to 18 hour without any stationary phase during the course of 
incubation. Immediate bacteriostatic effect was reflected for majority of compounds (MS1, 4-11) 
that persisted for 2-4 hours but bacterial growth rate was declined between 2nd to 4th hours against 
MS2, 3. The highest degrees of dampened growth were observed against certain nickel 
compounds (MS7, 8, 9) showing relative bacteriostatic efficiency of those compounds. The 
bacterial strain recovered the growth potential against all compounds except the one nickel 
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compound (MS9) and the ligand (MS1) implying the highest antibacterial efficiency of MS9 
against E. aerogenes. From the study on bacterial growth kinetics in presence of the tested 
compounds as well as the ligand it was evident that the compounds offered varied potential for 
inhibiting bacterial growth and therefore they may be promoted as bacteriostatic agents depending 
on the class and species of the pathogenic bacteria. 
The compounds tested in the present study might have increased the permeability of the cell 
membranes which has led the compounds to penetrate the cell and cause bacterial growth 
inhibition or death.  It has been found that enhancement of antimicrobial activity occurred for a 
thiosemicarbazone complex containing a bulkier substituent present at the N(4) position 
compared to an un-substituted one or one containing less bulkier substituent. The presence of the 
bulkier substituent is possibly responsible for an increase in lipophilicity of the complex, which 
influences the tendency of a molecule to be transported through biological membranes [22]. 
Although the present study does not show any direct experimental evidence about the mechanism 
of antibacterial activity of the Co and Ni complexes, it can be corroborated with our previous 
observation of membrane damage as inflicted by some Ni, Cd and Hg complexes against Gram 
positive (Bacillus subtilis 6633) and Gram negative (Proteus vulgaris OX19) bacterial strain [77]. 
In such cases the complexes might have caused membrane damage and consequent physiological 
disruption and bacteriostatic/bactericidal action. Such antimicrobial activity may arise on 
coordination to the metal ion and can be explained in terms of Overtone’s concept of cell 
permeability [78] and Tweedy’s chelation therapy [79]. According to the former concept, the lipid 
membrane surrounding the cell favors the passage of only lipid-soluble materials which thereby 
enhance the lipophilic character and thereby the complexes enable interaction with the cell 
constituents. On the other hand, chelate formation reduces the polarity of the metal centre to a 
considerable extent due to overlapping of the ligand orbital and partial sharing of the positive 
charge of the metal ion with the donor atoms. Also the rigidity of the primary ligand molecule in 
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the complexes may facilitate the interaction [80, 81]. Nonetheless, soft and borderline metal 
atoms as well as metal oxy-anions show electron-sharing affinities to facilitate formation of 
covalent bonds with S and consequent generation of protein disulphides and depletion of 
antioxidant reserves, particularly glutathione, within the microbial cells [82]. Depletion of total 
thiols in the cellular environment has been observed under the metal stress condition developed 
due to some metals like Co(II)    following the bacterial exposure to such toxic assault. The 
enzymes involved in thiol–disulphide homeostasis mediated by glutathione, glutaredoxin and 
thioredoxin systems are important determinants of bacterial tolerance to all those metals [82, 83]. 
In other words, synthetic compounds with metal salt anions could deplete the protective 
antioxidant system of the bacteria and can serve the role of antimicrobial agents. 
 
4.  Conclusion:  
The present communication deals with the syntheses, spectral characterizations and antibacterial 
activities of a host of Co(III) and Ni(II) complexes of the ligand, 5-methyl-3-formylpyrazole-
N(4)-dihexylthiosemicarbazone, (HMPzNHex2), along with the crystal structures and DFT 
calculations of [Co(MPzNHex2)2]ClO4·1.5H2O and [Ni(HMPzNHex2)2]Cl2·2H2O. All the 
reported metal ion complexes are octahedral in nature and the bonding of the primary ligand with 
Co(III) / Ni(II) centre, in each case, takes place through the pyrazolyl tertiary ring nitrogen atom, 
azomethine nitrogen atoms and the thiolato/ thione sulphur atoms. It has been found that 
although the ligand and all the synthesized metal complexes are capable of inhibiting microbial 
growth as bacteriostatic candidates, the cobalt complexes can be promoted as better antimicrobial 
agents.  
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Figure Captions: 
 
 
Figure 1: (a) Structural formulation of the ligand (HMPzNHex2); (b) General Structural 
representation of Co(III) complexes; (c) General Structural representation of Ni(II) complexes. 
 
Figure 2: Frontier molecular orbitals involved in UV–Vis absorptions in complex I.  
Figure 3: Frontier molecular orbitals involved in UV–Vis absorptions in complex II.  
Figure 4: View of the asymmetric unit (crystallographic numbering) of Complex I.  Thermal 
ellipsoids are drawn at the 50 % probability level except for disordered carbon atoms which are 
drawn as spheres of arbitrary radii. Minor components of disorder omitted for clarity. 
 
 
Figure 5:  View of the asymmetric unit (crystallographic numbering) of Complex II.  Thermal 
ellipsoids are drawn at the 50 % probability level except for disordered carbon atoms which are 
drawn as spheres of arbitrary radii. Minor components of disorder omitted for clarity. 
 
 
Figure 6:  (a) View down the crystallographic a-axis of the two-dimension hydrogen-bonded 
sheet formed by Complex I, lying in the (1 0 0) plane. Hydrogen bonds may be seen between 
ClO4
– and water oxygens, and pyrazolyl nitrogens. Hydrogen atoms not involved in hydrogen 
bonding, minor disorder components and the C6 chains omitted for clarity. Both positions of the 
disordered water molecule are included.  (b) View down the crystallographic b-axis of the 
packing of Complex I, hydrogen atoms and minor disorder components omitted for clarity. 
 
 
Figure 7:  (a) View of the one-dimension hydrogen-bonded chain formed by Complex II, 
running along the ac diagonal axis. View is from orthogonal to the chain. Hydrogen bonds may 
be seen between Cl–, water oxygens and pyrazolyl and hydrazinic nitrogens. Hydrogen atoms not 
involved in hydrogen bonding and minor disorder components omitted for clarity.  (b) View 
down the crystallographic b-axis of the packing of Complex II, hydrogen atoms and minor 
disorder components omitted for clarity. 
 
 
Figure 8:   DFT optimised structures of the complexes I and II 
 
 
Figure 9: Time dependent in vitro growth curves of Enterobacter aerogenes 10102 against the 
ligand and compounds: (a) MS1, (b) MS2, (c) MS3, (d) MS4, (e) MS5, (f) MS6, (g) MS7,        
(h) MS8, (i) MS9, (j) MS10 and (k) MS11 
 
 
Figure 10: Time dependent in vitro growth curves of Bacillus subtilis 6633 against the ligand 
and compounds: (a) MS1, (b) MS2, (c) MS3, (d) MS4, (e) MS5, (f) MS6, (g) MS7, (h) MS8,           
(i) MS9, (j) MS10 and (k) MS11. 
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Table 1:   Elemental analyses, colours and other significant physico-chemical properties of the 
Co(III) and  Ni(II) complexes 
 
Complex                                            Elemental analyses Found (calc.)                     Conductivity at 300C    µeff (BM) at 300K 
 (colour)                                                               Ω-1cm2mol-1 
                                                           %C                  %H               %N           %M 
 
[Co(MPzNHex2)2]Cl                        54.2 (54.4)     8.0 (8.1)    17.7 (17.6)     7.3 (7.4)                   88                        dia 
    (red brown) 
 
[Co(MPzNHex2)2]Br                        51.1 (51.5)     7.6 (7.7)     16.9 (16.7)     6.9 (7.0)                   96                        dia     
    (red orange)         
               
[Co(MPzNHex2)2]ClO4·1.5H2O      48.7 (48.8)     7.2 (7.3)     15.7 (15.8)      6.7 (6.6)                113                        dia   
     (red orange)    
                                           
[Co(MPzNHex2)2]BF4                    50.9 (51.1)     7.4 (7.6)      16.8 (16.5)      6.6 (6.9)                108                        dia    
    (dark red brown)    
                       
[Co(MPzNHex2)2]NO3                    52.7 (52.6)    7.8 (7.8)      17.1 (17.0)      7.0 (7.2)                  91                        dia    
    (dark red brown)   
               
[Ni(HMPzNHex2)2]Cl2·2H2O         49.3 (49.8)    7.4 (7.6)      16.4 (16.1)       6.9 (6.8)                202                       2.88  
       (green)             
      
[Ni(HMPzNHex2)2]Br2                   46.8 (46.9)    7.0 (7.2)       15.3 (15.2)       6.5 (6.4)                182                       3.20 
      (light green)    
                
[Ni(HMPzNHex2)2](ClO4)2            45.0 (45.0)    6.8 (6.9)      14.6 (14.6)       6.0 (6.1)                 195                       3.08   
      (dark green)        
           
[Ni(HMPzNHex2)2] (BF4)2             46.3 (46.2)    7.2 (7.1)      15.0 (15.0)       6.2 (6.3)                 172                       2.95   
     (dark green)       
        
 [Ni(HMPzNHex2)2](NO3)2            48.8 (48.8)   7.6 (7.5)       15.9 (15.8)       6.5 (6.6)                 177                       3.18   
       (light green)             
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Table 2: Vertical excitations with band position, oscillator strength and character assignments 
______________________________________________________________________________
Complex    Experimental         Wave length obtained    Oscillator          Maximum orbital          percentage     Transition 
                 wave length (nm)      from TD-DFT (nm)     strength (f)           contribution                    (%)           Assignment   
______________________________________________________________________________________________________   
 
     I              391.49                         359.67                     0.0311              HOMO- > L+2                  36%          L  M+L 
 
                     325.51                         292.93                       0.13                H-1- > LUMO                   50%           L  L 
                     227.82                         234.97                       0.13                H- 4- > LUMO                  60%           L  L 
 
      II            359.15                         322.86                       0.044            HOMO- > LUMO               70%           L  M 
                                                                                                                                                                      (Ligand assisted) 
                                                                                                                                                                                                                                                                                                                                           
                    307.39                         288.59                        0.28               H-1- > L+1                        38%            L  L 
                    223.29                         209.4                          0.15               H-1- > L+4                        57%            L  L 
______________________________________________________________________________ 
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                                                                                                                           Table 3:   1H NMR data (in CDCl3) for HMPzNHex2 and its Co(III) complexes relative to TMS 
 
                                                                                                                          Compound           -NH   Azomethine   Ring (Pz)   Ring (Pz)     Ring (Pz)  -N-(CH2-C5)2    -N-(C-CH2-C4)2  -N-(C2-(CH2)3-C)2  -N-(C5-CH3)2  
 
                                                                                                                                                  (imino)    -C-H         N1-H        C5-CH3            C4-H   
  
                                                                                                                        HMPzNHex2               11.51         7.27            12.83           2.34             6.12              3.64                1.65                3 (1.23)                   0.79 
                                                                                                                                  [Co(MPzNHex2)2]Cl                        8.39           12.99           2.58             6.16              3.78                1.70                 3 (1.27)                   0.81 
                                                                                                                                  [Co(MPzNHex2)2]Br                        8.42           12.89           2.49             6.19              3.76                1.66                 3 (1.27)                   0.84 
                                                                                                                                  [Co(MPzNHex2)2]ClO4·1.5H2O       8.39           12.99           2.59             6.17              3.74                1.67                 3 (1.27)                   0.89 
                                                                                                                                  [Co(MPzNHex2)2]BF4                                 8.41           12.92           2.52             6.15              3.71                1.69                 3 (1.27)                   0.88 
                                                                                                                                  [Co(MPzNHex2)2]NO3                      8.44           12.95           2.57             6.18               3.73               1.71                  3 (1.27)                 0.83 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 28  
Table 4: Crystal data and structure refinement parameters for Complex I   & Complex II   
 [Co(MPzNHex2)2]ClO4·1.5H2O (I) [Ni(HMPzNHex2)2]Cl2·2H2O (II) 
Empirical formula  C36H67ClCoN10O5.5S2 C36H70Cl2N10NiO2S2 
Formula weight  886.50 868.74 
Crystal description orange prism green prism 
Crystal size [mm3] 0.18×0.12×0.05 0.27×0.10×0.03 
Temperature [K] 125 125 
Wavelength [Å] 0.71075 0.71075 
Crystal system monoclinic triclinic 
Space group  C2/c  P-1 
a [Å] 41.887(6) 10.867(4) 
b [Å] 9.0663(11) 13.428(5) 
c [Å] 25.397(3) 17.055(5) 
α [°]  77.16(2) 
β [°] 105.335(3) 74.464(19) 
γ [°]  86.80(2) 
Volume [Å]3 9301(2) 2337.8(14) 
Z 8 2 
ρ (calc) [g/cm3] 1.266 1.234 
μ [mm-1] 0.556 0.659 
F(000) 3784 932 
Reflections collected 60145 30168 
Independent reflections (Rint) 8502 (0.0779) 8492 (0.2002) 
Data/restraints/parameters 8502 / 168 / 563 8492 / 423 / 498 
GOF on F2 1.022 1.069 
R1 [I > 2σ(I)] 0.0571 0.1707 
wR2 (all data) 0.1645 0.4666 
Largest diff. peak/hole [e/Å3] 0.79, -0.61 2.53, -1.04 
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Table 5.  Selected bond lengths (Å) and bond angles (°) of C
36
H
67
ClCoN
10
O
5.5
S
2
 (I) 
 and C
36
H
70
Cl
2
N
10
NiO
2
S
2
(II) .       
Bond lengths Complex_I Complex_II 
 Crystal Calculated Crystal Calculated 
M1-S10 2.2057(11) 2.2822 2.417(5) 2.28268 
M1-S40 2.2182(11) 2.28026 2.413(5) 2.80159 
M1-N1 1.936(3) 1.97245 2.071(14) 1.96424 
M1-N31 1.935(3) 1.97269 2.046(15) 2.59343 
M1-N8 1.899(3) 1.93754 2.042(12) 1.93087 
M1-N38 1.902(3) 1.9393 2.046(12) 1.96702 
N9-C10 1.331(5) 1.32957 1.36(2) 1.36435 
N39-C40 1.321(5) 1.33045 1.36(2) 1.37235 
S10-C10 1.741(4) 1.766448 1.681(15) 1.72823 
S40-C40 1.747(4) 1.76612 1.716(16) 1.69979 
Angle     
S10-M1-N31 89.98(10) 90.604 91.3(4) 99.769 
S40-M1-N1 91.32(9) 90.873 92.4(4) 88.017 
S10-M1-N8 85.59(9) 84.792 80.2(4) 85.555 
S40-M1-N38 85.40(10) 84.892 80.3(4) 75.953 
S10-M1-N1 167.28(9) 166.282 157.7(4) 166.192 
S40-M1-N31 167.08(10) 166.44 157.5(4) 145.881 
S10-M1-N38 96.85(9) 95.89 104.7(4) 94.521 
S40-M1-N8 97.14(9) 95.607 102.7(4) 109.352 
N1-M1-N8 81.80(12) 81.702 77.7(5) 81.007 
N8-M1-N31 95.75(13) 97.764 99.6(5) 174.622 
N1-M1-N38 95.68(13) 97.592 97.2(5) 98.560 
N31-M1-N38 81.69(14) 81.711 77.2(6) 74.681 
N1-M1-N31 89.65(13) 88.858 89.5(6) 79.588 
N8-M1-N38 176.45(13) 179.136 174.1(6) 174.622 
N8-N9-C10 111.2(3) 113.388 117.0(12) 118.506 
N38-N39-C40 112.1(3) 113.311 119.3(13) 123.006 
S10-M1-S40 91.87(4) 92.826 95.32(19) 99.484 
(M1= Co1= Ni1)      
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     Table 6:  Hydrogen bonding distances (Å) and angles (°) 
 
D-H...A                                     D.....A                             D-H                         H.....A     D-H...A 
 
 
   Complex I 
     
N2-H2···O1A                            3.037(10)                      0.935(19)                       2.19(3)                     151(4)   
N2-H2···O62 2.792(7)                        0.935(19)                       1.93(3)                       152(4)  
N32-H32···O61 2.810(5)                        0.972(19)                       1.85(2)                       171(4) 
O61··· O11 2.783(9) 
O61··· O42 2.830(10) 
O62···O23 3.063(11) 
O62···O2 3.010(13) 
 
Complex II 
 
 N2-H2···O61  2.713(19)                        0.98                            1.73                  177.8    
 N9-H9···Cl2  3.179(13)                        0.98                            2.42                  133.6    
N32-H32···O62  2.748(17)                        0.98                            1.77                  175.5 
 N39-H39···Cl14  3.198(16)                        0.98                            2.41                  136.9   
O61···Cl15  3.127(14) 
O61···Cl14  3.132(15) 
O62···Cl26  3.114(12) 
 O62···Cl2                   3.127(14)  
 
Symmetry Operators: (1) 1–X, 1+Y, ½–Z; (2) X, 1+Y, Z; (3) 1–X, –Y, 1–Z 
                                    (4) –1+X, Y, Z; (5) 1–X, 1–Y, –Z; (6) 1–X, 1–Y, 1–Z 
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Table 7: The minimum inhibitory  concentrations (MIC, µg/mL) of the ligand and the synthesized Co(III) & 
Ni(II) compounds against three Gram negative bacteria (Salmonella enterica ser. typhi SRC, Proteus 
vulgaris OX19, Enterobacter aerogenes 10102) and one Gram positive bacteria (Bacillus subtilis 6633) 
 
Organisms MS1 MS2 MS3 MS4 MS5 MS6 MS7γ MS8γ MS9γ MS10γ MS11γ AM* 
P.  vulgaris 
OX19 
200 875 725 650 375 450 1350 1575 775 1000 1375 125 
B.  subtilis 
6633 
300 600 575 350 225 575 1200 1375 1075 900 1450 30 
S. typhi 
SRC 
475 1375 1225 650 575 700 1300 1450 650 625 1500 35 
E. 
aerogenes 
10102 
500 1675 1400 675 600 1050 1650 1525 950 975 1025 280 
AM*= Amoxicillin – the antibiotic which was used as the standard antimicrobial agent in the present 
study.MS1= HMPzNHex2. [Co(MPzNHex2)2]X (X= Cl, Br, ClO4, BF4 and NO3 for MS2, MS3, MS4, MS5 
and MS6, respectively. γ[Ni(HMPzNHex2)2]Y2 (Y= Cl, Br, ClO4, BF4 and NO3 for MS7, MS8, MS9, MS10 
and MS11, respectively. 
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Table 8: Growth inhibition zone diameter (mm) developed when different bacterial strains were subjected to         
respective MICs of the ligand and Co(III) & Ni(II) compounds tested. The means of inhibition zone measured 
were presented with respected standard deviation. 
AM*= Amoxicillin, the antibiotic which was used as the standard antimicrobial agent in the present 
study. 
 
 
 
Organis
ms 
MS1 MS2 MS3 MS4 MS5 MS6 MS7 MS8 MS9 MS10 MS11 AM* 
P.  
vulgaris 
OX19 
2.3±0.1 2.7±0.
3 
2.3±0.1 2.6±0.2 2.5±0.2 2.1±0.1 3.3±0.2 3.0±0.1 3.7±0.3 3.1±0.4 2.3±0.2 7.9±
0.3 
B. 
subtilis 
6633 
2.7±0.2 4.3±0.
3 
3.6±0.4 3.3±0.1 2.6±0.2 4.4±0.4 2.7±0.3 2.3±0.1 2.6±0.2 3.4±0.4 3.3±0.1 8.4±
0.4 
S.  typhi 
SRC 
2.5±0.1 3.1±0.
2 
3.9±0.3 6.8±0.2 2.1±0.3 1.9±0.1 6.9±0.1 6.2±0.2 5.9±0.4 6.8±0.2 9.1±0.3 9.1±
0.2 
E. 
aerogen
es 10102 
5.3±0.3 4.3±0.
5 
3.3±0.2 4.3±0.4 3.7±0.2 2.7±0.1 3.7±0.3 5.4±0.2 7.3±0.4 5.3±0.1 5.7±0.2 8.5±
0.3 
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A new pyrazole containing Thiosemicarbazone ligand and its octahedral Co(III) and Ni(II) 
complexes have  been synthesized & characterized. The reported NNS tridentate ligand 
(HMPzNHex2) binds with the metal ion via the pyrazolyl tertiary nitrogen, the azomehine 
nitrogen and the sulphur in its thione / thiol form. The structural conformations of Co(III) and 
Ni(II) complexes have been established by X-ray studies and DFT calculations of 
[Co(MPzNHex2)2]ClO4·1.5H2O (I)  and [Ni(HMPzNHex2)2]Cl2·2H2O (II). The detailed 
antimicrobial activities of the title ligand and all the complexes have been reported.  
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Highlights (for review) 
Syntheses, physico-chemical and spectroscopic characterizations of new pyrazole containing 
Thiosemicarbazone ligand and its Co(III) and Ni(II) complexes have been reported. 
X-ray crystallographic studies on Complex I and II have authenticated the structures of the 
complexes as envisaged from spectroscopy. 
Antimicrobial activities of the complexes against some Gram positive and Gram negative bacteria have been 
reported, and the complexes have been found to be the potential antimicrobial agents in broad 
spectrum against the both. 
 
 
    
 
 
